BIOMERICA INC Increase (Decrease) in Contract with Customer, Liability
BIOMERICA INC (BMRA) reported Increase (Decrease) in Contract with Customer, Liability of $28.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-31
- BIOMERICA INC increase (decrease) in contract with customer, liability for the quarter ending 2026-05-31 was $53.00K.
- BIOMERICA INC increase (decrease) in contract with customer, liability for the quarter ending 2026-02-28 was $0.00.
- BIOMERICA INC increase (decrease) in contract with customer, liability for the quarter ending 2025-11-30 was -$24.00K.
- BIOMERICA INC increase (decrease) in contract with customer, liability for the quarter ending 2025-08-31 was -$1.00K.
- BIOMERICA INC increase (decrease) in contract with customer, liability for fiscal 2026 was $28.00K.
- BIOMERICA INC increase (decrease) in contract with customer, liability for fiscal 2025 was -$30.00K, a 220.00% decline from fiscal 2024.
- BIOMERICA INC increase (decrease) in contract with customer, liability for fiscal 2024 was $25.00K, a 177.78% increase from fiscal 2023.
- BIOMERICA INC increase (decrease) in contract with customer, liability for fiscal 2023 was $9.00K, a 82.35% decline from fiscal 2022.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $53.00K derived: sum of 2 quarters · filed 2026-08-31 | $29.00K derived: sum of 3 quarters · filed 2026-08-31 | $28.00K 10-K · filed 2026-08-31 | ||||
| 2026-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | -$24.00K derived: sum of 2 quarters · filed 2026-04-13 | -$25.00K 10-Q · filed 2026-04-13 | -$25.00K derived: sum of 4 quarters · filed 2026-08-31 | ||||
| 2025-11-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | -$25.00K 10-Q · filed 2026-01-14 | -$25.00K derived: sum of 3 quarters · filed 2026-08-31 | |||||
| 2025-08-31 | -$1.00K 10-Q · filed 2025-10-14 | -$1.00K derived: sum of 2 quarters · filed 2026-08-31 | ||||||
| 2025-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | -$30.00K 10-K · filed 2026-08-31 | ||||||
| 2025-02-28 | -$30.00K 10-Q · filed 2026-04-13 | |||||||
| 2024-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $25.00K 10-K · filed 2025-08-29 | ||||||
| 2024-02-29 | $25.00K 10-Q · filed 2024-04-12 | |||||||
| 2023-05-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $11.00K derived: sum of 2 quarters · filed 2024-08-28 | -$91.00K derived: sum of 3 quarters · filed 2024-08-28 | $9.00K 10-K · filed 2024-08-28 | ||||
| 2023-02-28 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-12 | -$13.00K derived: sum of 2 quarters · filed 2024-04-12 | $87.00K 10-Q · filed 2024-04-12 | $87.34K 10-Q · filed 2023-04-14 | -$3.08M derived: sum of 4 quarters · filed 2024-04-12 | |||
| 2022-11-30 | -$102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | -$2.00K 10-Q · filed 2024-01-16 | -$1.66K 10-Q · filed 2023-01-13 | -$3.16M derived: sum of 3 quarters · filed 2024-01-16 | -$2.10M derived: sum of 4 quarters · filed 2024-01-16 | |||
| 2022-08-31 | $100.00K 10-Q · filed 2023-10-12 | $99.85K 10-Q · filed 2022-10-13 | -$3.06M derived: sum of 2 quarters · filed 2023-10-12 | -$2.00M derived: sum of 3 quarters · filed 2023-10-12 | ||||
| 2022-05-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | -$2.10M derived: sum of 2 quarters · filed 2023-08-25 | $51.00K 10-K · filed 2023-08-25 | $50.67K 10-K · filed 2022-08-29 | ||||
| 2022-02-28 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-14 | $3.21M 10-Q · filed 2023-04-14 | ||||||
| 2021-11-30 | $2.15M 10-Q · filed 2023-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |